Merrill: Confidence...
Health Care: Drugs
Amgen Inc (AMGN: NASDAQ)
$104.24 2.06 | 2.02%
05/21/13 - 04:00 PM ET
Portfolios with AMGN
- Portfolio NameUser Type
- ContributorTechnical Setups for the We...
- ContributorHigh Volume Technicals for ...
- UserDividend Stocks
- ContributorTechnical Setups for the We...
- ContributorTechnical Setups for the We...
- UserStevo
- ContributorPotential Dividend Hikes fo...
- UserMike Fatah's Mega Stock Por...
- UserGFNN Stockdiagnostics 23
- UserLong Term Stock Picks
Latest AMGN Headlines from TheStreet
- Amgen Inc (AMGN): Today's Featured Health Care Winner 05.21.13 | 05:05 pm
- AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward 05.16.13 | 01:05 pm
- Amgen Inc (AMGN): Today's Featured Drugs Winner 05.14.13 | 05:05 pm
- 5 Stocks Going Ex-Dividend Tomorrow: HR, PMT, CNP, GG, AMGN 05.13.13 | 10:05 am
- Amgen Stock To Go Ex-dividend Tomorrow (AMGN) 05.13.13 | 09:05 am
- Amgen Inc (AMGN): Today's Featured Health Care Laggard 05.06.13 | 05:05 pm
- 5 Stocks Dragging In The Health Care Sector 05.06.13 | 01:05 pm
- All the Reasons in the World to Pull Back 05.04.13 | 06:05 am
- Analysts' Actions: AMGN BIIB DWA FCX ULTI 05.01.13 | 08:05 am
- BMY, CELG And AMGN, 3 Drugs Stocks Pushing The Industry Lower 04.29.13 | 01:04 pm
Press Releases for AMGN
- Amgen To Present At The UBS Global Life Sciences Conference - PR Newswire 05.16.13 | 04:05 pm
- Amgen Highlights Data To Be Presented At American Society Of Clinical Oncology Annual Meeting - PR Newswire 05.15.13 | 06:05 pm
- Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China - PR Newswire 05.09.13 | 04:05 pm
- Four Californians Selected As Breakaway From Cancer® Champions To Be Honored During Amgen Tour Of California - PR Newswire 05.01.13 | 04:05 pm
- Amgen Announces Webcast Of 2013 First Quarter Financial Results - PR Newswire 04.18.13 | 04:04 pm
- Pharmaceutical Companies, Investor Coalition Develop Industry Standard-Setting Principles For Recoupment Policies Covering Major Compliance Failures - PR Newswire 04.04.13 | 08:04 am
- Amgen Announces Top-Line Results Of Phase 3 Talimogene Laherparepvec Trial In Melanoma - PR Newswire 03.19.13 | 06:03 pm
- Amgen Announces 2013 Second Quarter Dividend - PR Newswire 03.06.13 | 04:03 pm
- Amgen To Present At The Cowen And Company 33rd Annual Health Care Conference - PR Newswire 03.01.13 | 04:03 pm
- Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients - PR Newswire 02.22.13 | 05:02 pm
Partner Headlines for AMGN
- Big Cap Leaders Slide But Show Little Technical Damage - Investor's Business Daily 04.15.13 | 07:04 pm
- Pockets of Strength In Top Groups, Few Leaders Basing - Investor's Business Daily 04.15.13 | 06:04 pm
- Stocks End With Mild Losses; Nasdaq Rises 2.8% For Week - Investor's Business Daily 04.12.13 | 05:04 pm
- Can New Psoriasis Drugs Scratch Investors' Itch? - Investor's Business Daily 04.04.13 | 01:04 pm
- Cree, Seagate, Sandisk: Why Richie Freeman Likes Them - Investor's Business Daily 04.02.13 | 06:04 pm
- Biotech Breakout Boosting ETFs - Benzinga 03.28.13 | 03:03 pm
- Wall St rises as Fed reaffirms policies - Financial Times 03.20.13 | 08:03 pm
- Celgene Leads Handful Of Big Cap Stocks To New Highs - Investor's Business Daily 03.11.13 | 06:03 pm
- When To Add A New Full Position In A Good Stock - Investor's Business Daily 03.11.13 | 06:03 pm
- PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for March 01, 2013 - NASDAQ 02.27.13 | 02:02 pm
